Aspira Women's Health Inc
NASDAQ:AWH

Watchlist Manager
Aspira Women's Health Inc Logo
Aspira Women's Health Inc
NASDAQ:AWH
Watchlist
Price: 0.027 USD -67.07% Market Closed
Market Cap: $23.5m

Operating Margin

-177.3%
Current
Improving
by 63.4%
vs 3-y average of -240.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-177.3%
=
Operating Income
$-16.3m
/
Revenue
$9.2m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-177.3%
=
Operating Income
$-16.3m
/
Revenue
$9.2m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Aspira Women's Health Inc
NASDAQ:AWH
23.5m USD
Loading...
US
Abbott Laboratories
NYSE:ABT
190.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
140.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.4B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
131.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.1B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.1B USD
Loading...

Market Distribution

Lower than 87% of companies in the United States of America
Percentile
13th
Based on 14 112 companies
13th percentile
-177.3%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Aspira Women's Health Inc
Glance View

Market Cap
23.5m USD
Industry
Health Care

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. The company is headquartered in Austin, Texas and currently employs 106 full-time employees. The company went IPO on 2000-09-29. Its products include OVA1 and Overa, OVA1plus, Aspira GenetiX and Aspira Synergy. OVA1 is a blood test that is intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician’s independent clinical, and Overa is intended to maintain OVA1’s high sensitivity. OVA1plus is a reflex test performed for those OVA1 test results that are in the intermediate risk range. Aspira GenetiX is a genetic test for gynecologic cancer risk, with a focus on female reproductive cancers, including breast, ovarian, endometrial, uterine and cervical cancers. Aspira Synergy is an en-suite, cloud-based technology transfer solution that provides an end-to-end solution from specimen collection to a customized white-label report for clinical laboratories to internalize testing of its products.

AWH Intrinsic Value
0.126 USD
Undervaluation 79%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-177.3%
=
Operating Income
$-16.3m
/
Revenue
$9.2m
What is Aspira Women's Health Inc's current Operating Margin?

The current Operating Margin for Aspira Women's Health Inc is -177.3%, which is above its 3-year median of -240.6%.

How has Operating Margin changed over time?

Over the last 3 years, Aspira Women's Health Inc’s Operating Margin has increased from -478.7% to -177.3%. During this period, it reached a low of -498.8% on Mar 31, 2022 and a high of -177.3% on Jan 31, 2025.

Back to Top